The World Federation of Hemophilia (WFH) is proud to announce the launch of Activity #4 in Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education (CME) program developed in collaboration with the National Hemophilia Foundation, the European Haemophilia Consortium and Medscape Education. The program is designed for clinicians but is available to everyone.
Why Gene Therapy for Hemophilia: Exploring the Challenges of Current Therapies
Johnny Mahlangu, BSc, MBBCh, MMed, FCPath, John Pasi, MB ChB, PhD, FRCP, FRCPath, FRCPCH
0.25 CME/ABIM MOC. Released August 30, 2018 and valid for credit through August 30, 2019.
Why Gene Therapy for Hemophilia: Exploring the Challenges of Current Therapies is an expert video exchange on gene therapy in the context of therapies currently available for hemophilia around the world. Watch as world renowned hematologists, John Pasi (London, U.K.) and Johnny Mahlangu (Johannesburg, South Africa) consider the advantages, disadvantages and unknowns of gene therapy in hemophilia, and the potential for this technology in countries with limited resources. A transcript of the discussion in Activity #4 makes it easy for all learners to follow along, and presentation slides containing useful illustrations and key messages enhance the learning experience.
The program of five activities covers important information on the science behind gene therapy for hemophilia, the latest safety and efficacy data from clinical trials and the potential role for gene therapy in addressing the challenges of current treatment options. Clinicians can qualify for CME credits for each activity, and all learners can obtain a completion certificate, or simply use the program to enhance their knowledge of gene therapy in hemophilia. Browse the other activities in this program, and remember to check back often as the final activity, a clinical article describing recent advances in hemophilia gene therapy trials, will go live over the coming month.
To learn about Activity #1, “Test Your Knowledge of Gene Therapy for Hemophilia”, and Activity #2, “Gene Therapy: Past, Present, and Future”, please click here. To learn about Activity #3, “The Science of Gene Therapy for Hemophilia”, please click here.